Intricon Names Chief Technology and Chief Financial Officers
Bristol Myers Squibb Launches Disability Diversity in Clinical Trials (DDiCT) Initiative to Improve Healthcare Outcomes for People with Disabilities
Luminary Therapeutics Selected as a 2022/2023 Showcase Company in NIH/NCI’s Investor Initiative Program
GE Unveils Brand Names for Three Planned Future Public Companies